Stereotaxis (STXS) Cash from Investing Activities (QoQ) (2010 - 2026)
Stereotaxis (STXS) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.86% |
| Dec 31, 2024 | -102.04% |
| Sep 30, 2023 | -100.05% |
| Jun 30, 2023 | 5,866.19% |
| Mar 31, 2023 | 98.26% |
| Dec 31, 2022 | -9,697.56% |
| Sep 30, 2022 | 68.46% |
| Jun 30, 2022 | 43.67% |
| Mar 31, 2022 | 3.51% |
| Dec 31, 2021 | -2,245.10% |
| Sep 30, 2021 | 56.03% |
| Jun 30, 2021 | -241.18% |
| Dec 31, 2019 | -127.60% |
| Mar 31, 2019 | 0.96% |
| Dec 31, 2018 | 95.00% |
| Sep 30, 2018 | -323.88% |
| Jun 30, 2018 | -369.21% |
| Mar 31, 2018 | -5.21% |
| Dec 31, 2017 | 85.99% |
| Dec 31, 2015 | -1,169.14% |